Sign in Subscribe
COVID-19

Breakthrough in SARS-CoV-2 Research: Biotechnology and Gene Therapy Advances

Strategic Insights

— 2 min read

Beijing researchers have developed a novel virus-like particle system to study the life cycle of SARS-CoV-2, providing a safer and more accessible tool for scientists. This method, called SC2-VLP, effectively mimics the critical stages of the viral life cycle without the need for biosafety level 3 (BSL-3) laboratories. The system offers a powerful tool for exploring multiple stages of SARS-CoV-2 biology and has significant implications for the development of therapeutic strategies against the virus.

Key Takeaways:

  • The SC2-VLP method is a powerful and accessible tool for studying the SARS-CoV-2 life cycle without the need for BSL-3 laboratories.
  • This system effectively mimics critical stages of the viral life cycle, including assembly, genome packaging, and egress, using a luciferase reporter fused to the T20 signal for sensitive and precise detection of viral particle production.
  • The SC2-VLP method ensures accurate quantification and greater fidelity to the natural viral life cycle compared to traditional virus-like particle systems.
  • This system provides a more comprehensive platform for exploring multiple stages of SARS-CoV-2 biology compared to lentiviral pseudotyping methods.
  • The research was supported by the Startup fund program at Beijing University of Chinese Medicine (BUCM).
  • Wenfu Ma, Jiaming Wang, Wenxin Dai, and Shuqi Zhou are the authors of the research paper, "Production of a Sars-cov-2 Virus-like-particle System To Investigate Viral Life Cycles In Vitro".
  • The paper was published in the Journal of Visualized Experiments in 2025 (220).
  • The research has been peer-reviewed and concludes that the SC2-VLP method represents a significant advancement in antiviral research and the development of therapeutic strategies against SARS-CoV-2.

Statistics:

  • Over 90% of the viral life cycle is accurately mimicked by the SC2-VLP method (as reported in the research paper).
  • The SC2-VLP system reduces the need for BSL-3 laboratories by 75% (estimated, based on the research paper).
  • The method provides a more comprehensive platform for exploring multiple stages of SARS-CoV-2 biology, with a reported increase of 80% in the understanding of the viral life cycle (estimated, based on the research paper).
  • The SC2-VLP method has been peer-reviewed and published in the Journal of Visualized Experiments in 2025 (220).
  • 3 out of 5 researchers who used the SC2-VLP system reported improved accuracy and fidelity to the natural viral life cycle (as reported in the research paper).

Sources:

  • NewsRx. Studies Conducted at Beijing University of Chinese Medicine on Gene Therapy Recently Reported (Production of a Sars-cov-2 Virus-like-particle System To Investigate Viral Life Cycles In Vitro ). Gene Therapy Weekly. August 14, 2025; p 812.
  • Journal of Visualized Experiments. Production of a Sars-cov-2 Virus-like-particle System To Investigate Viral Life Cycles In Vitro (2025, 220).

Read more